| Pharmaceutical Information |
| Drug Name |
Biguanide |
| Drug ID |
BADD_D00273 |
| Description |
Biguanide has been investigated for the treatment of Diabetes Mellitus. |
| Indications and Usage |
|
| Marketing Status |
Not Available |
| ATC Code |
Not Available |
| DrugBank ID |
DB13100
|
| KEGG ID |
Not Available
|
| MeSH ID |
D001645
|
| PubChem ID |
5939
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| Synonyms |
Biguanides | Biguanide |
|
| Chemical Information |
| Molecular Formula |
C2H7N5 |
| CAS Registry Number |
56-03-1 |
| SMILES |
C(=NC(=N)N)(N)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Anaphylactic shock | 10.01.07.002; 24.06.02.004 | - | - | Not Available | | Angioedema | 23.04.01.001; 10.01.05.009 | - | - | Not Available | | Injection site pain | 12.07.03.011; 08.02.03.010 | - | - | Not Available | | Pain | 08.01.08.004 | - | - | | | Urticaria | 23.04.02.001; 10.01.06.001 | - | - | |
|
The 1th Page
1
Total 1 Pages
|
|
